vs

Side-by-side financial comparison of KKR Real Estate Finance Trust Inc. (KREF) and TriSalus Life Sciences, Inc. (TLSI). Click either name above to swap in a different company.

KKR Real Estate Finance Trust Inc. is the larger business by last-quarter revenue ($25.8M vs $13.2M, roughly 2.0× TriSalus Life Sciences, Inc.). TriSalus Life Sciences, Inc. runs the higher net margin — -73.9% vs -101.7%, a 27.9% gap on every dollar of revenue. On growth, TriSalus Life Sciences, Inc. posted the faster year-over-year revenue change (59.8% vs -26.6%). Over the past eight quarters, TriSalus Life Sciences, Inc.'s revenue compounded faster (43.0% CAGR vs -18.8%).

KKR Real Estate Finance Trust Inc. is a specialized real estate finance firm sponsored by global investment firm KKR. It primarily originates, acquires, and manages a portfolio of senior secured commercial real estate loans, mostly backed by high-quality institutional commercial properties across the United States, delivering stable risk-adjusted returns to investors via interest income from its diversified assets.

TriSalus Life Sciences, Inc. is a clinical-stage biotechnology company focused on advancing immuno-oncology and interventional oncology solutions. It develops proprietary targeted drug delivery technologies designed to improve treatment efficacy for patients with liver, pancreatic and other hard-to-treat solid tumors, primarily operating in North American markets via partnerships with clinical care and research institutions.

KREF vs TLSI — Head-to-Head

Bigger by revenue
KREF
KREF
2.0× larger
KREF
$25.8M
$13.2M
TLSI
Growing faster (revenue YoY)
TLSI
TLSI
+86.4% gap
TLSI
59.8%
-26.6%
KREF
Higher net margin
TLSI
TLSI
27.9% more per $
TLSI
-73.9%
-101.7%
KREF
Faster 2-yr revenue CAGR
TLSI
TLSI
Annualised
TLSI
43.0%
-18.8%
KREF

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
KREF
KREF
TLSI
TLSI
Revenue
$25.8M
$13.2M
Net Profit
$-26.2M
$-9.8M
Gross Margin
86.7%
Operating Margin
-105.1%
-24.8%
Net Margin
-101.7%
-73.9%
Revenue YoY
-26.6%
59.8%
Net Profit YoY
-229.6%
3.5%
EPS (diluted)
$-0.49
$-0.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
KREF
KREF
TLSI
TLSI
Q4 25
$25.8M
$13.2M
Q3 25
$25.3M
$11.6M
Q2 25
$30.2M
$11.2M
Q1 25
$31.3M
$9.2M
Q4 24
$35.1M
$8.3M
Q3 24
$37.0M
$7.3M
Q2 24
$40.4M
$7.4M
Q1 24
$39.1M
$6.5M
Net Profit
KREF
KREF
TLSI
TLSI
Q4 25
$-26.2M
$-9.8M
Q3 25
$13.8M
$-10.8M
Q2 25
$-29.7M
$-8.3M
Q1 25
$-4.9M
$-10.4M
Q4 24
$20.3M
$-10.1M
Q3 24
$-7.4M
$-2.4M
Q2 24
$25.8M
$-4.3M
Q1 24
$-3.1M
$-13.2M
Gross Margin
KREF
KREF
TLSI
TLSI
Q4 25
86.7%
Q3 25
83.5%
Q2 25
83.9%
Q1 25
83.7%
Q4 24
85.3%
Q3 24
86.3%
Q2 24
87.6%
Q1 24
85.0%
Operating Margin
KREF
KREF
TLSI
TLSI
Q4 25
-105.1%
-24.8%
Q3 25
50.4%
-77.9%
Q2 25
-101.3%
-65.4%
Q1 25
-18.3%
-79.9%
Q4 24
55.8%
-91.8%
Q3 24
-19.6%
-118.9%
Q2 24
63.3%
-111.0%
Q1 24
-8.7%
-180.8%
Net Margin
KREF
KREF
TLSI
TLSI
Q4 25
-101.7%
-73.9%
Q3 25
54.4%
-93.5%
Q2 25
-98.5%
-73.9%
Q1 25
-15.5%
-113.2%
Q4 24
57.7%
-122.4%
Q3 24
-20.0%
-32.6%
Q2 24
63.9%
-58.8%
Q1 24
-7.9%
-204.5%
EPS (diluted)
KREF
KREF
TLSI
TLSI
Q4 25
$-0.49
$-0.22
Q3 25
$0.12
$-0.96
Q2 25
$-0.53
$-0.27
Q1 25
$-0.15
$-0.39
Q4 24
$0.22
$-0.38
Q3 24
$-0.19
$-0.12
Q2 24
$0.29
$-0.21
Q1 24
$-0.13
$-0.60

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
KREF
KREF
TLSI
TLSI
Cash + ST InvestmentsLiquidity on hand
$84.6M
$20.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.2B
$-33.9M
Total Assets
$6.5B
$35.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
KREF
KREF
TLSI
TLSI
Q4 25
$84.6M
$20.4M
Q3 25
$204.1M
$22.7M
Q2 25
$107.7M
$26.5M
Q1 25
$106.4M
$13.0M
Q4 24
$104.9M
$8.5M
Q3 24
$108.8M
$11.3M
Q2 24
$107.2M
$16.5M
Q1 24
$106.5M
$4.0M
Stockholders' Equity
KREF
KREF
TLSI
TLSI
Q4 25
$1.2B
$-33.9M
Q3 25
$1.2B
$-26.7M
Q2 25
$1.2B
$-19.4M
Q1 25
$1.3B
$-34.4M
Q4 24
$1.3B
$-25.9M
Q3 24
$1.4B
$-20.4M
Q2 24
$1.4B
$-25.3M
Q1 24
$1.4B
$-36.0M
Total Assets
KREF
KREF
TLSI
TLSI
Q4 25
$6.5B
$35.3M
Q3 25
$6.5B
$36.5M
Q2 25
$6.8B
$41.3M
Q1 25
$6.6B
$28.6M
Q4 24
$6.4B
$24.0M
Q3 24
$6.8B
$27.5M
Q2 24
$7.1B
$32.4M
Q1 24
$7.3B
$17.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
KREF
KREF
TLSI
TLSI
Operating Cash FlowLast quarter
$72.3M
$-2.5M
Free Cash FlowOCF − Capex
$-2.5M
FCF MarginFCF / Revenue
-19.1%
Capex IntensityCapex / Revenue
0.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-19.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
KREF
KREF
TLSI
TLSI
Q4 25
$72.3M
$-2.5M
Q3 25
$18.5M
$-3.7M
Q2 25
$21.1M
$-7.3M
Q1 25
$15.9M
$-4.5M
Q4 24
$132.6M
$-5.7M
Q3 24
$49.1M
$-10.8M
Q2 24
$30.6M
$-13.4M
Q1 24
$34.5M
$-10.9M
Free Cash Flow
KREF
KREF
TLSI
TLSI
Q4 25
$-2.5M
Q3 25
$-3.9M
Q2 25
$-7.4M
Q1 25
$-5.3M
Q4 24
$-5.8M
Q3 24
$-11.0M
Q2 24
$-13.5M
Q1 24
$-10.9M
FCF Margin
KREF
KREF
TLSI
TLSI
Q4 25
-19.1%
Q3 25
-33.9%
Q2 25
-66.1%
Q1 25
-57.3%
Q4 24
-69.7%
Q3 24
-149.9%
Q2 24
-183.1%
Q1 24
-169.3%
Capex Intensity
KREF
KREF
TLSI
TLSI
Q4 25
0.3%
Q3 25
1.9%
Q2 25
0.8%
Q1 25
8.2%
Q4 24
0.6%
Q3 24
2.3%
Q2 24
0.8%
Q1 24
1.0%
Cash Conversion
KREF
KREF
TLSI
TLSI
Q4 25
Q3 25
1.34×
Q2 25
Q1 25
Q4 24
6.54×
Q3 24
Q2 24
1.19×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons